High speed chronic total occlusion crossing devices

Information

  • Patent Grant
  • 11147583
  • Patent Number
    11,147,583
  • Date Filed
    Thursday, July 18, 2019
    4 years ago
  • Date Issued
    Tuesday, October 19, 2021
    2 years ago
Abstract
An occlusion crossing device includes an outer shaft, an inner shaft, an optical fiber, and a handle attached to the inner shaft and the outer shaft. The inner shaft extends within the outer shaft. The inner shaft includes a drill tip at a distal end thereof. The optical fiber extends within the inner shaft substantially along a central axis of the inner shaft. The distal tip of the optical fiber is attached to the drill tip. The handle is configured to rotate the inner shaft and drill tip at speeds of greater than 500 rpm.
Description
INCORPORATION BY REFERENCE

All publications and patent applications mentioned in this specification are herein incorporated by reference to the same extent as if each individual publication or patent application was specifically and individually indicated to be incorporated by reference.


BACKGROUND

Peripheral artery disease (PAD) and coronary artery disease (CAD) affect millions of people in the United States alone. PAD and CAD are silent, dangerous diseases that can have catastrophic consequences when left untreated. CAD is the leading cause of death for in the United States while PAD is the leading cause of amputation in patients over 50 and is responsible for approximately 160,000 amputations in the United States each year.


Coronary artery disease (CAD) and Peripheral artery disease (PAD) are both caused by the progressive narrowing of the blood vessels most often caused by atherosclerosis, the collection of plaque or a fatty substance along the inner lining of the artery wall. Over time, this substance hardens and thickens, which may interfere with blood circulation to the arms, legs, stomach and kidneys. This narrowing forms an occlusion, completely or partially restricting flow through the artery. Blood circulation to the brain and heart may be reduced, increasing the risk for stroke and heart disease.


Interventional treatments for CAD and PAD may include endarterectomy and/or atherectomy. Endarterectomy is surgical removal of plaque from the blocked artery to restore or improve blood flow. Endovascular therapies such as atherectomy are typically minimally invasive techniques that open or widen arteries that have become narrowed or blocked. Other treatments may include angioplasty to open the artery. For example, a balloon angioplasty typically involves insertion of a catheter into a leg or arm artery and positioning the catheter such that the balloon resides within the blockage. The balloon, connected to the catheter, is expanded to open the artery. Surgeons may then place a wire mesh tube, called a stent, at the area of blockage to keep the artery open.


Such minimally invasive techniques (e.g., atherectomy, angioplasty, etc.) typically involve the placement of a guidewire through the occlusion. Using the guidewire, one or more interventional devices may be positioned to remove or displace the occlusion. Unfortunately, placement of the guidewire, while critical for effective treatment, may be difficult. In particular, when placing a guidewire across an occlusion, it may be difficult to pass the guidewire through the occlusion while avoiding damage to the artery. For example, it is often difficult to prevent the guidewire from directing out of the lumen into the adventitia and surrounding tissues, potentially damaging the vessel and preventing effective treatment of the occlusion.


As a result, occlusion-crossing devices, intended to assist in the passing of the guidewire through the occlusion, have been developed. Many of the devices, however, are ill equipped to be used with imaging, thereby making placement of the guidewire cumbersome and difficult. Moreover, many of the occlusion-crossing devices are too large to be used in small-diameter peripheral arteries or in coronary arteries.


Accordingly, occlusion crossing catheter devices designed to address some of these concerns are described herein.


SUMMARY OF THE DISCLOSURE

Described herein are occlusion-crossing devices having a low profile and a distal drill tip. In some embodiments, an articulating feature can provide for steering or directionality of the device. In some embodiments, an inner shaft can be removable from an outer shaft.


In general, in one embodiment, an occlusion crossing device includes an outer shaft, an inner shaft, an optical fiber, and a handle attached to the inner shaft and the outer shaft. The inner shaft extends within the outer shaft. The inner shaft includes a drill tip at a distal end thereof. The optical fiber extends within the inner shaft substantially along a central axis of the inner shaft. The distal tip of the optical fiber is attached to the drill tip. The handle is configured to rotate the inner shaft and drill tip at speeds of greater than 500 rpm.


This and other embodiments can include one or more of the following features. The inner shaft and optical fiber can be removable from the outer shaft. The handle can include a luer lock configured to lock and unlock the inner shaft relative to the outer shaft. The outer shaft can include an articulating feature configured to allow the outer shaft to bend. The articulating feature can be activated by moving the inner shaft along the central axis relative to the outer shaft. The articulating feature can include a backbone and a plurality of circumferential cuts. The inner shaft can include an annular member configured to engage with an inner lip of the outer shaft to bend the outer shaft when the inner shaft is pushed distally. The inner shaft can include an annular member configured to engage with an inner lip of the outer shaft to bend the outer shaft when the inner shaft is pulled proximally. The outer shaft can include a preformed bend therein. The outer shaft can further include a marker positioned with respect to the preformed bend such that an orientation of the outer shaft can be determined during imaging. The outer shaft can include a transparent distal portion configured to allow imaging with the optical fiber therethrough. The handle can be configured to rotate the inner shaft and drill tip at speeds of greater than 1,000 rpm. The handle can be configured to rate the inner shaft and drill tip at speeds of greater than 500 rpm such that images can be generated from the optical fiber at a rate of greater than or equal to 8 frames per second. The optical fiber can be a common path optical coherence tomography fiber. The drill tip can include a plurality of spiral cutting edges. The drill tip can be a substantially smooth frusto-conical tip. The imaging device can further include a monorail guidewire lumen extending along the outer shaft. An outer diameter of the outer shaft can be less than 0.08 inches.


In general, in one embodiment, a method of crossing an occlusion includes: (1) inserting a device into a vessel having an occlusion therein; (2) rotating an inner shaft of the device relative to an outer shaft of the device such that a drill tip on the inner shaft drills through the occlusion; and (3) generating images with an optical fiber extending through the inner shaft at a rate of greater than or equal to 8 frames per second while rotating the inner shaft.


This and other embodiments can include one or more of the following features. The method can further include removing the inner shaft from the outer shaft, and inserting a guidewire through the outer shaft. The method can further include bending a distal end of the device in order to steer the device through the vessel. Bending the distal end can comprise pushing or pulling on the inner shaft. The method can further include orienting a bend in the outer shaft in a desired direction. The method can further include using a marker on the device to orient the bend. Rotating the inner shaft can comprise rotating at more than 500 rpm.





BRIEF DESCRIPTION OF THE DRAWINGS

The novel features of the invention are set forth with particularity in the claims that follow. A better understanding of the features and advantages of the present invention will be obtained by reference to the following detailed description that sets forth illustrative embodiments, in which the principles of the invention are utilized, and the accompanying drawings of which:



FIGS. 1A-3B show an occlusion crossing device having an articulating feature.



FIGS. 4A-5C show an occlusion crossing device having separable inner and outer shafts.



FIGS. 6A and 6B are exemplary block diagrams of drive systems for the catheters described herein.



FIGS. 7A-7B show an exemplary method for detecting the position of the driveshaft of a catheter.



FIGS. 8A-8B show articulation of an occlusion crossing device having an articulating feature and separable inner and outer shafts.



FIGS. 9A and 9B show the inner shaft of the occlusion crossing device of FIGS. 8A-8B positioned inside of the outer shaft for cutting and imaging.



FIG. 10 shows the outer shaft of the occlusion crossing device of FIGS. 8A-8B with the inner shaft removed.



FIGS. 11A and 11B show an exemplary handle for use with the occlusion crossing device of FIGS. 8A-8B.



FIGS. 12 and 13 show another exemplary handle for use with the occlusion crossing device of FIGS. 8A-8B.



FIGS. 14A-14C show the distal portion of another embodiment of an occlusion crossing device.



FIG. 15 shows the occlusion crossing device FIGS. 1A-3B with a monorail guidewire lumen.





DETAILED DESCRIPTION

Described herein are occlusion-crossing devices having a low profile so as to be usable in small-diameter arteries and coronary arteries, e.g., through a 5 French catheter or smaller. In general, the devices described herein can have on-board imaging, such as optical coherence tomography (OCT) imaging. The optical fiber for OCT imaging can extend substantially along the central axis of the device, thereby decreasing the profile of the device and allowing for rotation at high speeds. The devices can also include a rotatable pointed tip, allowing for forward drilling. In some embodiments, the device can include an articulating distal end to enable steering of the device.


Referring to FIGS. 1A-3B, in one embodiment, an exemplary catheter 100 includes an outer shaft 122 and an inner driveshaft 131 connected to a distal tip 103. The elongate outer shaft 122 can be hollow and can have an inner diameter of approximately 1 mm and an outer diameter of approximately 1.5 mm. In some embodiments, the outer shaft 122 can have a coiled construction, whereby the coils are wound by laying one coil over another. For example, the shaft 122 can include at least two coil layers. Further, the coil layers can be counter-wound, such that one coil layer, such as the inner coil layer, has a left hand lay and another layer, such as the outer coil layer, has a right hand lay. The coil can provide torque in the direction that tightens the outer layer, cinching down on the inner layer. A third counter wound coil can be added to generate torque in both directions. In another embodiment, the shaft 122 is made of a braided wire reinforced polymeric shaft. In yet another embodiment, the shaft 122 can be a laser-cut tube. The outer shaft 122 can further include one or more imaging windows 144 at a distal end thereof.


A bushing 124 (see FIG. 1D) can be attached to the shaft 122, such as through a tab and slot mechanism 148. The bushing 124 can act as a bearing surface relative to the inner shaft or tip 103. Further, the bushing 124 can include edges or lips 151, 152 on either side configured to interact with the inner driveshaft 131 or the tip 103, as discussed further below.


The tip 103 can be configured, for example, to separate, dissect, or shred tissue. In some embodiments, the tip 103 can include sharp spiraling flutes 113 that come to a point in the center of the device. Further, the flutes 113 can be angled such that they have sharper edges when rotated in one direction than in another direction. As a result, the tip 103 with flutes 113 can have an active and passive modes depending upon the direction of rotation of the tip 103. In passive mode, the tip 103 with flutes 113 can be less aggressive, providing blunt dissection of tissue. In active mode, the tip 103 with flutes 113 can be more aggressive, providing cutting and auguring to make its way through harder material. In some embodiments, as described further below with respect to FIGS. 14A and 14B, the distal tip 103 can have a smooth angled surface that is non-fluted.


The inner driveshaft 131 (see FIG. 1D) can be connected to the distal tip 103 and can extend down the center of the outer shaft 122. The inner driveshaft 131 can be configured to rotate in either a single direction or in both the clockwise and counterclockwise directions so as to rotate the tip 103 relative to the shaft 122 (about the bushing 124) in either a single direction or in the clockwise or counterclockwise direction. Annular rings 174, 172 can be positioned around a distal portion of the inner driveshaft 131 and/or the tip 103. The rings 174, 172 can be positioned against the edges 151, 152 of the bushing 124. The annular bushing 124 can allow relative rotation of the inner driveshaft 131 relative to the bushing 124 while preventing axial movement (and allowing for articulation in some embodiments, as described further below).


In some embodiments, a distal portion of the outer shaft 122 can include an articulating feature 145. As shown in FIGS. 1A and 1B, the articulating feature 145 can include one or more backbones 245a, b and a series of circumferential cuts 247 and 295. The one or more backbones can be positioned on only one side of the catheter (e.g., span less than 180 degrees, less than 150 degrees, or less than 90 degrees). In some embodiments, and as shown in FIG. 1A, a series of small circumferential cuts 295 can extend between the two backbones 245a, b in order to provide added flexibility during bending. The circumferential cuts 247, 295 can be configured as incomplete rings or spirals about the outer shaft 122. Referring to FIG. 1B, in some embodiments, the circumferential cuts 247 can include one or more breaks 297a,b therein designed to provide additional tensile strength and compression resistance for the articulating feature 145.


The articulating feature 145 can be attached to the inner driveshaft 131 such that movement of the driveshaft 131 can activate the articulating feature. Further, in some embodiments, a handle 200 (see FIGS. 2B and 3B) can be used to activate movement of the driveshaft 131.


Referring to FIGS. 2A-2B, as the driveshaft 131 is pushed distally, the annular ring 172 can push distally on the proximal lip 152 of the bushing 124 (see FIG. 1D), causing the circumferential cuts 247 to spread apart or open while the backbones 245a,b maintain their length (and the circumferential cuts 295 move closer together). As a result, the articulating feature 145 can bend towards the backbones 245a,b. As shown in FIG. 2B, this bending mechanism can be activated on the handle 200, such as by moving a ring 303 distally and/or pushing or moving a button or lever.


Likewise, referring to FIGS. 3A-3B, as the driveshaft 131 is pulled proximally, the annular ring 174 can hit the distal lip 151 of the bushing 124. As further distal force is applied by the driveshaft 131, the circumferential cuts 247 can begin to move closer together and/or the material between the cuts 247 can overlap while the backbones 245a,b maintain their length (and the cuts 295 move further apart). As a result, the articulating feature 145 can bend towards the circumferential cuts 247 and away from the backbones 245a,b. As shown in FIG. 3B, this bending mechanism can be activated on the handle 200, such as by moving the ring 303 proximally and/or pushing or moving a button or lever.


The bending movement of the articulating feature 145 can advantageously allow the device 100 to be steered when used in the vessel, such as for re-entry if the tip extends out of the occlusion or lumen. In some embodiments, the catheter 100 can be configured to bend in only one direction by either pushing or pulling on the driveshaft 131 and return to the straight configuration shown in FIG. 1A by movement of the driveshaft 131 in the opposite direction.


The catheter 100 can further include an imaging element 199 attached to the driveshaft 131 and configured to rotate therewith. The imaging element 199 can be the distal end of an OCT fiber 119 extending down the center of the driveshaft 131. The imaging element 199 can provide imaging (through windows 144) as the catheter 100 is used in the vessel, thereby assisting in occlusion crossing.


Referring to FIG. 15, in some embodiments, a monorail guidewire lumen 1505 can extend along the outer shaft 122. The guidewire lumen 1505 can run, for example, between the two backbones 245a,b so as to not add additional stiffness to the flexible area with the circumferential cuts 247.


In some embodiments, the catheter 100 can be used with a sheath. The sheath can be hollow and include a hemostasis valve attached at the proximal end with a flush port on the side to facilitate flushing through the sheath. The sheath can also facilitate guidewire placement to the target site, particularly for embodiments of the catheter 100 that do not include a monorail guidewire lumen. That is, the catheter 100 can be used to cross the occlusion, the sheath can be placed thereover, the device removed, and then the guidewire can be introduced.


Referring to FIGS. 4A-5C, in another embodiment, an exemplary catheter 300 includes an inner shaft 311, an outer shaft 322, and a distal tip 303 connected to the inner shaft 311. Further, the outer shaft 322 can be separable from the inner shaft 311. For example, the inner shaft 311 can include a luer connector near the proximal end that is attachable and detachable from a luer connector on a proximal end of the outer shaft 322, as described below with respect to handle 900.


In some embodiments, a distal portion 313 of the outer shaft 322 can be clear or transparent, such as made of a clear or transparent plastic, in order to allow imaging therethrough. In some embodiments, the outer shaft 322 can further include a preformed bend 329 therein to help orient or steer the device. A marker 315, such as a metal marker, can extend within the distal portion 313 to indicate the relative orientation of the catheter 300 when in use. For example, as shown in FIG. 4B, the innermost portion of the bend 329 can align with the marker 315.


Further, in some embodiments, the inner shaft 311 can move longitudinally within the hollow outer shaft 322 by sliding a ring on a handle (such as handle 200) connected to the catheter 300 to allow the inner shaft 311 to be exposed (as shown in FIGS. 4A-4B) or fully covered (as shown in FIGS. 5A-5C). In use, the inner shaft 311 can thus be extended out of the outer shaft to help drill through the occlusion and pulled in when dissection is not required (or when only blunt dissection is required). In some embodiments, the inner shaft 311 can be configured to be fixed at various points relative to the outer shaft 322 so as to vary the amount of exposed tip 103. Further, the shaft 311 can be fully removed from the outer shaft 322 to allow for placement of a guidewire therethrough.


Further, the device 300 can include an imaging element 399 similar to as described above with respect to device 100. The catheter 300 can be configured to image with the imaging element 399 both when the inner shaft 311 is extended distally out of the outer shaft 322 and when the inner shaft 311 is positioned within the outer shaft 322 (through the transparent distal portion 313).


The device 300 can further or alternatively include any of the features, materials, and/or dimensions described above with respect to device 100.


Referring to FIGS. 8A-10, in another embodiment, an exemplary catheter 800 can include both a separable inner shaft 811 and outer shaft 822 and an articulating feature 845 on the distal end of the outer shaft 822.


Referring to FIGS. 8A-8B, the articulating feature 845 can include a backbone 945 and a series of circumferential cuts 947. Further, as shown in FIG. 9A, a collar 860 attached to the outer shaft 822 can include an inner ledge 862 configured to extend radially inwards relative to the outer shaft 822. Likewise, the inner shaft 811 can include an annular member 872, such as a plastic bearing, that has a greater diameter than the rest of the inner shaft 811. Thus, when the inner shaft 811 is pushed distally, the annular member 872 of the inner shaft 811 can push against the inner ledge 862 of the collar 860. As a result, the outer shaft 822 can bend at the cuts 947 towards the backbone 945 (as shown by the arrows in FIG. 9A).


As shown in FIG. 10, the inner shaft 811 can be fully removable from the outer shaft 822 and collar 860 by pulling the inner shaft 811 proximally. By doing so, the outer shaft 822 can be used as a sheath, e.g., for guidewire placement.


Further, the inner shaft 811 can include an imaging element 877 element similar to as described above with respect to devices 100 and 300 that is rotatable with the inner shaft 811. The imaging element 877 can image through imaging windows 866 in the collar 860. Further, the inner ledge 862 can also function to properly align the imaging element 877 with the imaging windows 866 when the inner shaft 811 is within the outer shaft 822.


The inner shaft 811 can include a rotatable distal tip 803 similar to as described above with respect to devices 100 and 300. Likewise, the device 800 can alternatively or additionally include any of the materials and dimensions described above with respect to devices 100 and 300.


Referring to FIGS. 11A-11B, a handle 900 can be used to operate the device 800. The handle 900 can include a luer lock 883 configured to lock the inner shaft 811 and outer shaft 822 together longitudinally. The luer lock 883 can be configured to provide some relative longitudinal movement between the outer shaft 822 and the inner shaft 811 such that the inner shaft 811 can still move a small distance, such as between about 0.125 inches to 0.2 inches, to activate the articulating feature 845. For example, the inner shaft 811 can include an accordion or elastomeric segment to provide the additional relative movement. The actual displacement distance depends on the diameter of the outer shaft of the catheter, the degree of bending that is desired and the elongation/compression of the outer and inner shaft, respectively. The larger the diameter of the outer shaft, the greater the desired degree of bending, and the more compression/elongation of the shafts, the greater the required amount of displacement. Further, the luer lock 883 can be configured to allow the inner shaft 811 to rotate freely within the outer shaft so as to provide rotation of the sharp distal tip 803 connected to the inner shaft 811. The luer lock 883 can be configured such that the outer shaft can be rotated relative to the position of the handle. With the shaft in the articulated position, rotating the outer shaft will direct the catheter around or towards obstacles during use. If the luer lock 883 is disconnected, as shown in FIG. 11B, the inner shaft 811 can be pulled out of the outer shaft 822 by the handle, leaving the outer shaft 822 in place, such as for guidewire placement.


The handle 900 can further include a lever 885 or ring configured to control the axial movement of the inner shaft 811 (and thus the articulation of the device 800). In some embodiments, the lever 885 can include a locking mechanism that allows the device 800 to stay bent at a set angle. The handle 900 can also include a rotation element 893 attached to the outer shaft 822 and configured to rotate the outer shaft 822, such as 360 degrees, to position the bend of the device 800 in the desired orientation.


Another exemplary handle 1000 is shown in FIGS. 12-13. The handle 1000 can include many of the features of handle 900. A slide button 1085 can be used to control the axial movement of the inner shaft. The rotation element 1093 can be configured to rotate the outer shaft 822.


Furthermore, in some embodiments, the connection between the outer and inner shafts within the handle can be configured such that the two shaft snap together, axially fixing the proximal ends together, but allowing them to rotate independently. In other embodiments, a third element could be used to key, link, or peg the two shafts together.


Features of the handles 900, 1000, though described for use with catheter 800, can likewise be used with catheters 100, 300.


The distal end of another embodiment of a catheter 1400 is shown in FIGS. 14A-14B. The catheter 1400 is similar to catheters 100, 300, 800 except that it includes a smooth distal tip 103 and a molded distal portion 1410. Thus, the distal tip 103 can have a smooth angled surface 1413 that is non-fluted and comes together in a slightly convex distal point 1415 (i.e., the tip can be frusto-conical). The distal tip 103 of FIGS. 14A, 14B can advantageously provide less aggressive drilling through the occlusion. The distal tip 103 of FIGS. 14A and 14B can be used in place of any of the distal tips described with respect to catheters 100, 300, 800. Likewise, the catheter 1400 can include a molded distal portion 1422. The molded distal portion 1422 can be similar to the distal end of the catheter 300 and can include a bushing 1424, a transparent section 1422, and the scaffolding 1452 of the outer shaft. Further, an imaging fiber 1499 can run down the central axis of the device, as described above with respect to other embodiments. Any of the features of catheter 100, 300, 800 can be used in addition to, or as an alternative to, the features described with respect to catheter 1400. Likewise, the catheter 1400 can be used with a handle having some or all of the features of handles 200, 900, or 1000.


In some embodiments, all or a portion of the outer shaft of the catheters described herein can be clear to allow imaging therethrough. Further, in some embodiments, the catheters described herein can include a balloon to occlude for better imaging. The balloon can be a clear balloon to allow imaging therethrough.


As described above, the catheters 100, 300, 800, 1400 can include an imaging element. The imaging element can include an optical fiber, such as an optical coherence tomography (OCT) imaging fiber. The optical fiber can extend within the driveshaft or inner shaft so as to extend substantially along the central axis of the catheter for the entire length of the fiber. The fiber can be attached at the distal end of the driveshaft or inner shaft and/or the distal tip, but can be otherwise free to float within the driveshaft. The imaging fiber can transfer an OCT signal for imaging of the vessel in which the device is placed. In some embodiments, the imaging fiber can have a polyimide coating therearound within the length of the driveshaft to support and protect the fiber as it spins within the driveshaft. Further, the handles described herein can be configured to accommodate a certain amount of slack in the fiber to facilitate extension and retraction of drive shaft against hollow shaft.


The imaging element can further include a mirror oriented at an angle (such as a 30-60 degree angle, e.g., 45 degrees) with respect to the central axis of the fiber such that light coming out of the fiber will bounce off the mirror and into the adjacent tissue. Glue can be used to hold the distal end of the optical fiber in place. The glue can have a refractive index configured to be appropriately mismatched with the refractive index of the fiber, as described in U.S. patent application Ser. No. 12/790,703, titled “OPTICAL COHERENCE TOMOGRAPHY FOR BIOLOGICAL IMAGING,” filed May 28, 2010, Publication No. US-2010-0305452-A1; and International Patent Application No. PCT/US2013/031951, titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING,” filed Mar. 15, 2013, both of which are incorporated by reference in their entireties. Further, the glue can have a meniscus shape along its outer edge, as described in International Patent Application No. PCT/US2013/031951 titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING,” filed Mar. 15, 2013, incorporated by reference herein. The meniscus shape can advantageously ensure that the light reflected back from the surface of the glue and back into the fiber is significantly less than the light referenced.


The driveshaft or inner shaft, and thus the imaging element or optical fiber, can be configured to rotate continuously at high speeds, such as greater than 500 rpm, greater than 600 rpm, greater than 700 rpm, greater than 800 rpm, greater than 900 rpm, or greater than 1,000 rpm, e.g., between 500-1,000 rpm, in one or both directions to provide OCT imaging around the inner circumference of the vessel. Such high speed rotation in a single direction or in different directions as chosen by the user (as opposed to requiring rotation alternately in both directions to manage the optical fiber) allows for the gathering of image data more quickly, thereby providing more accurate and up-to-date images during use of the device 100. For example, images can be generated at a rate of greater than 6 frames per section (fps), such as greater than or equal to 8 fps or greater than or equal to 10 fps, such as approximately 16.67 fps. In an exemplary embodiment, the rate of Laser sweep, such as approximately 20 KHz, can be configured to keep up with at 16.67 frames per second with about 1200 lines per frame.


Advantageously, because the optical fiber runs through the center of the catheters described herein, the catheters can be small in diameter. For example, the outer diameter of the catheters described herein can be less than 0.10″, such as less than 0.08″, such as less than 0.07″, less than 0.06″, or less than 0.05″. Accordingly, the catheters described herein can advantageously be used in small-diameter peripheral arteries and coronary arteries.


In some embodiments, the catheters described herein can be configured to be attached to a drive system. The drive system can include a rotary optical junction configured to rotate the fiber. Exemplary drive systems that could be used in conjunction with the devices herein are described in U.S. patent application Ser. No. 13/654,357, titled “ATHERECTOMY CATHETERS AND NON-CONTACT ACTUATION MECHANISM FOR CATHETERS,” filed Oct. 17, 2012 and International Patent Application No. PCT/US2013/032089, titled “ATHERECTOMY CATHETER DRIVE ASSEMBLIES,” filed Mar. 15, 2013, each incorporated herein by reference in its entirety.


In some embodiments, the drive system can communicate with the control system via a communication bus, which in some embodiments can be a CAN bus 2.0B. This communication can be employed to convey status to the control system or console, such as direction, speed, run status, and other information. It can also be employed to send control information to the drive system, such as run command, speed, direction, and setting of parameters for compensations of mechanical characteristics of the catheters. Referring to FIG. 6A, in one embodiment, a drive processor 1601 is used as the main controlling element for the drive system. The drive processor 1601 controls the motor 1603 through a motor controller 1602, which receives commands and returns status from/to the drive processor 1601. The drive processor 1601 can, in addition to simple speed and direction control, also implement algorithms to optimize catheter performance. The drive processor 1601 communicates with the control system (e.g., the console for the device) via the CAN controller 1604 to send and receive commands and status. In addition, in this embodiment a switch 1605 on the drive processor 1601 housing allows local control of the run state. The switch 1605 can be replaced with alternative hardware inputs, such as buttons, toggles, or knobs.


Further, in some embodiments the drive system can communicate with the catheter via NFC or RFID to obtain information about the catheter. As an example, this information can include catheter type, optimal rotational speed and direction, serial number, amongst many possible parameters. Referring to FIG. 6B, the drive system communicates with the catheter via a NFC/RFID reader 1606 and a NFC/RFID tag 1607 in the catheter to obtain information stored in the tag.


The drive system can be configured to allow the driveshaft and cutter to rotate continuously in the clockwise or the counterclockwise direction depending upon user preference. Therefore, in some embodiments, the drive system can include a user-addressable switch, such as a toggle, to set the desired direction.


Further, in some embodiments, the drive system can include a mechanism to determine the amount of rotation of the driveshaft in the clockwise or counterclockwise directions. Referring to FIGS. 6A and 6B, in one embodiment, for example, the drive system can provide information related to the direction of the motor. Speed and direction can be sensed by the control system (or console) by a data line in the umbilical, which can be a dedicated line or a multiplexed signal. The dedicated line can carry an analog or a digital signal. In one embodiment, a dedicated voltage line carries six discrete velocities (vector speed+direction) that are interpreted by the control system or console in order to infer speed and direction of the catheter.


Referring to FIGS. 7A-7B, in on embodiment, a flag in the drive system can include either an asymmetric design or an asymmetric positioning of the flags around the motor (see FIG. 7A). A controller can then sense motor direction by detecting the distinct series of flag spacing and/or width, as shown in FIG. 7B.


Further, in some embodiments, the drive system can be configured to rotate the driveshaft at several discrete rates and/or include a knob to allow for user-chosen continuously variable speeds.


Any of the catheters described herein can be shape-set or include shape-set features to enhance trackability and navigability.


As used herein, an imaging element can include the OCT optical fiber, such as the distal end of the optical fiber, as well as the mirror and adhesive used to hold the mirror and optical fiber in place.


As described above, the catheters described herein can include optical coherence tomography imaging, such as common path OCT. Such OCT systems are described in U.S. patent application Ser. No. 12/829,267, titled “CATHETER-BASED OFF-AXIS OPTICAL COHERENCE TOMOGRAPHY IMAGING SYSTEM,” filed Jul. 1, 2010, Publication No. US-2010-0021926-A1; U.S. patent application Ser. No. 12/790,703, titled “OPTICAL COHERENCE TOMOGRAPHY FOR BIOLOGICAL IMAGING,” filed May 28, 2010, Publication No. US-2010-0305452-A1; and International Patent Application PCT/US2013/031951 titled “OPTICAL COHERENCE TOMOGRAPHY WITH GRADED INDEX FIBER FOR BIOLOGICAL IMAGING,” filed Mar. 15, 2013, all of which are incorporated by reference in their entireties. Alternatively, other types of imaging could be used with the catheters described herein. For example, the devices described herein could be configured to work with infrared spectroscopy or ultrasound.


The catheters 100, 300, 800, 1400 described herein can be used for occlusion-crossing within blood vessels. Advantageously, the devices can advantageously provide increased trackability through bending/steering and high imaging speed during such crossing.


Additional details pertinent to the present invention, including materials and manufacturing techniques, may be employed as within the level of those with skill in the relevant art. The same may hold true with respect to method-based aspects of the invention in terms of additional acts commonly or logically employed. Also, it is contemplated that any optional feature of the inventive variations described may be set forth and claimed independently, or in combination with any one or more of the features described herein. Likewise, reference to a singular item, includes the possibility that there are a plurality of the same items present. More specifically, as used herein and in the appended claims, the singular forms “a,” “and,” “said,” and “the” include plural referents unless the context clearly dictates otherwise. It is further noted that the claims may be drafted to exclude any optional element. As such, this statement is intended to serve as antecedent basis for use of such exclusive terminology as “solely,” “only” and the like in connection with the recitation of claim elements, or use of a “negative” limitation. Unless defined otherwise herein, all technical and scientific terms used herein have the same meaning as commonly understood by one of ordinary skill in the art to which this invention belongs. The breadth of the present invention is not to be limited by the subject specification, but rather only by the plain meaning of the claim terms employed.


When a feature or element is herein referred to as being “on” another feature or element, it can be directly on the other feature or element or intervening features and/or elements may also be present. In contrast, when a feature or element is referred to as being “directly on” another feature or element, there are no intervening features or elements present. It will also be understood that, when a feature or element is referred to as being “connected”, “attached” or “coupled” to another feature or element, it can be directly connected, attached or coupled to the other feature or element or intervening features or elements may be present. In contrast, when a feature or element is referred to as being “directly connected”, “directly attached” or “directly coupled” to another feature or element, there are no intervening features or elements present. Although described or shown with respect to one embodiment, the features and elements so described or shown can apply to other embodiments. It will also be appreciated by those of skill in the art that references to a structure or feature that is disposed “adjacent” another feature may have portions that overlap or underlie the adjacent feature.


Terminology used herein is for the purpose of describing particular embodiments only and is not intended to be limiting of the invention. For example, as used herein, the singular forms “a”, “an” and “the” are intended to include the plural forms as well, unless the context clearly indicates otherwise. It will be further understood that the terms “comprises” and/or “comprising,” when used in this specification, specify the presence of stated features, steps, operations, elements, and/or components, but do not preclude the presence or addition of one or more other features, steps, operations, elements, components, and/or groups thereof. As used herein, the term “and/or” includes any and all combinations of one or more of the associated listed items and may be abbreviated as “/”.


Spatially relative terms, such as “under”, “below”, “lower”, “over”, “upper” and the like, may be used herein for ease of description to describe one element or feature's relationship to another element(s) or feature(s) as illustrated in the figures. It will be understood that the spatially relative terms are intended to encompass different orientations of the device in use or operation in addition to the orientation depicted in the figures. For example, if a device in the figures is inverted, elements described as “under” or “beneath” other elements or features would then be oriented “over” the other elements or features. Thus, the exemplary term “under” can encompass both an orientation of over and under. The device may be otherwise oriented (rotated 90 degrees or at other orientations) and the spatially relative descriptors used herein interpreted accordingly. Similarly, the terms “upwardly”, “downwardly”, “vertical”, “horizontal” and the like are used herein for the purpose of explanation only unless specifically indicated otherwise.


Although the terms “first” and “second” may be used herein to describe various features/elements, these features/elements should not be limited by these terms, unless the context indicates otherwise. These terms may be used to distinguish one feature/element from another feature/element. Thus, a first feature/element discussed below could be termed a second feature/element, and similarly, a second feature/element discussed below could be termed a first feature/element without departing from the teachings of the present invention.


As used herein in the specification and claims, including as used in the examples and unless otherwise expressly specified, all numbers may be read as if prefaced by the word “about” or “approximately,” even if the term does not expressly appear. The phrase “about” or “approximately” may be used when describing magnitude and/or position to indicate that the value and/or position described is within a reasonable expected range of values and/or positions. For example, a numeric value may have a value that is +/−0.1% of the stated value (or range of values), +/−1% of the stated value (or range of values), +/−2% of the stated value (or range of values), +/−5% of the stated value (or range of values), +/−10% of the stated value (or range of values), etc. Any numerical range recited herein is intended to include all sub-ranges subsumed therein.

Claims
  • 1. An occlusion crossing device comprising: a rotatable drive shaft having an optical fiber used to generate images and a distal end with a drill tip; andan outer shaft having a lumen for accommodating the drive shaft, the outer shaft removably coupled to the drive shaft such that the drive shaft can rotate within the lumen when coupled to the outer shaft, an inner portion of the outer shaft configured to engage with the drive shaft when a force is applied to the drive shaft in a longitudinal direction to bend the outer shaft.
  • 2. The occlusion crossing device of claim 1, wherein the outer shaft includes a backbone configured to bend the outer shaft in a predetermined direction when the force is applied to the drive shaft.
  • 3. The occlusion crossing device of claim 1, wherein a distal region of the outer shaft is configured to bend when the force is applied to the drive shaft.
  • 4. The occlusion crossing device of claim 1, wherein the optical fiber is configured to rotate with the drive shaft.
  • 5. The occlusion crossing device of claim 2, wherein the backbone causes the outer shaft to bend towards the backbone.
  • 6. The occlusion crossing device of claim 2, wherein the outer shaft includes circumferential cut on a side of the outer shaft opposite the backbone.
  • 7. The occlusion crossing device of claim 1, wherein the force is a pushing force applied in a distal direction or a pulling force applied in a proximal direction.
  • 8. The occlusion crossing device of claim 1, wherein the drive shaft includes an annular member configured to engage with an inner lip of the outer shaft to bend the outer shaft when the drive shaft is pushed distally.
  • 9. The occlusion crossing device of claim 1, wherein the drive shaft includes an annular member configured to engage with an inner lip of the outer shaft to bend the outer shaft when the drive shaft is pulled proximally.
  • 10. The occlusion crossing device of claim 1, wherein the drive shaft includes the optical fiber that extends through the drive shaft.
  • 11. The occlusion crossing device of claim 1, wherein the outer shaft further includes a guidewire lumen.
  • 12. The occlusion crossing device of claim 11, wherein the outer shaft includes circumferential cuts on a side of the outer shaft opposite the guidewire lumen.
  • 13. A method of crossing an occlusion, the method comprising: inserting a device into a blood vessel having an occlusion therein, the device having a drive shaft within a lumen of an outer shaft;bending the outer shaft by applying a force to the drive shaft in a longitudinal direction while the drive shaft is coupled with the outer shaft, wherein an inner portion of the outer shaft engages with the drive shaft when the force is applied to the drive shaft;rotating the drive shaft such that a drill tip at a distal end of the drive shaft drills through the occlusion;generating images of using an optical fiber coupled to the drive shaft; andremoving the drive shaft from the outer shaft while the outer shaft is in the blood vessel.
  • 14. The method of claim 13, wherein the outer shaft includes a backbone configured to bend the outer shaft in a predetermined direction when the force is applied to the drive shaft.
  • 15. The method of claim 14, further comprising inserting a guidewire through the outer shaft.
  • 16. The method of claim 13, further comprising generating the images while the optical fiber rotates with the drive shaft.
  • 17. The method of claim 13, wherein the draft shaft is displaced longitudinally by a distance of between about 0.125 inches to about 0.2 inches with respect to the outer shaft when the force is applied to the drive shaft.
  • 18. The method of claim 13, wherein the force is a pushing force applied in a distal direction or a pulling force applied in a proximal direction.
  • 19. The method of claim 13, wherein bending the outer shaft includes causing an annular member of the drive shaft to engage with an inner lip of the outer shaft.
CROSS REFERENCE TO RELATED APPLICATIONS

This application is a continuation of U.S. patent application Ser. No. 15/324,325, filed Jan. 6, 2017, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” now U.S. Pat. No. 10,357,277, which is a national phase application under 35 USC 371 of International Patent Application No. PCT/US2015/039585, filed Jul. 8, 2015, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” now International Publication No. WO 2016/007652, which claims priority to U.S. Provisional Patent Application No. 62/022,101, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” and filed Jul. 8, 2014 and U.S. Provisional Patent Application No. 62/073,850, titled “HIGH SPEED CHRONIC TOTAL OCCLUSION CROSSING DEVICES,” and filed Oct. 31, 2014, the entire contents of each are incorporated by reference herein.

US Referenced Citations (519)
Number Name Date Kind
3387727 Ward et al. Feb 1968 A
3908637 Doroshow Sep 1975 A
4178935 Gekhaman et al. Dec 1979 A
4487206 Aagard Dec 1984 A
4527553 Upsher Jul 1985 A
4552554 Gould et al. Nov 1985 A
4611600 Cohen Sep 1986 A
4621353 Hazel et al. Nov 1986 A
4639091 Huignard et al. Jan 1987 A
4651753 Lifton Mar 1987 A
4654024 Crittenden et al. Mar 1987 A
4681106 Kensey et al. Jul 1987 A
4686982 Nash Aug 1987 A
4691708 Kane Sep 1987 A
4729763 Henrie Mar 1988 A
4771774 Simpson et al. Sep 1988 A
4841977 Griffith et al. Jun 1989 A
4857046 Stevens et al. Aug 1989 A
4920961 Grossi et al. May 1990 A
4926858 Gifford, III et al. May 1990 A
5000185 Yock Mar 1991 A
5018529 Tenerz et al. May 1991 A
5041082 Shiber Aug 1991 A
5047040 Simpson et al. Sep 1991 A
5085662 Willard Feb 1992 A
5099850 Matsui et al. Mar 1992 A
5178153 Einzig Jan 1993 A
5182291 Gubin et al. Jan 1993 A
5190050 Nitzsche Mar 1993 A
5192291 Pannek, Jr. Mar 1993 A
5312415 Palermo May 1994 A
5312425 Evans et al. May 1994 A
5321501 Swanson et al. Jun 1994 A
5333142 Scheps Jul 1994 A
5358472 Vance et al. Oct 1994 A
5366464 Belknap Nov 1994 A
5372601 Lary Dec 1994 A
5383460 Jang et al. Jan 1995 A
5383467 Auer et al. Jan 1995 A
5425273 Chevalier Jun 1995 A
5429136 Milo et al. Jul 1995 A
5431673 Summers et al. Jul 1995 A
5437284 Trimble Aug 1995 A
5459570 Swanson et al. Oct 1995 A
5460168 Masubuchi et al. Oct 1995 A
5465147 Swanson Nov 1995 A
5507760 Wynne et al. Apr 1996 A
5507795 Chiang et al. Apr 1996 A
5517998 Madison May 1996 A
5556405 Lary Sep 1996 A
5607394 Andersen et al. Mar 1997 A
5620426 Braithwaite Apr 1997 A
5632754 Farley et al. May 1997 A
5632755 Nordgren et al. May 1997 A
5674232 Halliburton Oct 1997 A
5681336 Clement et al. Oct 1997 A
5690634 Muller et al. Nov 1997 A
5722403 McGee et al. Mar 1998 A
5728148 Bostrom et al. Mar 1998 A
5795295 Hellmuth et al. Aug 1998 A
5807339 Bostrom et al. Sep 1998 A
5830145 Tenhoff Nov 1998 A
5836957 Schulz et al. Nov 1998 A
5843050 Jones et al. Dec 1998 A
5843103 Wulfman Dec 1998 A
5851212 Zirps et al. Dec 1998 A
5868778 Gershony et al. Feb 1999 A
5872879 Hamm Feb 1999 A
5904651 Swanson et al. May 1999 A
5907425 Dickensheets et al. May 1999 A
5935075 Casscells et al. Aug 1999 A
5938602 Lloyd Aug 1999 A
5938671 Katoh et al. Aug 1999 A
5951482 Winston et al. Sep 1999 A
5951581 Saadat et al. Sep 1999 A
5951583 Jensen et al. Sep 1999 A
5956355 Swanson et al. Sep 1999 A
5957952 Gershony et al. Sep 1999 A
5987995 Sawatari et al. Nov 1999 A
5997558 Nash Dec 1999 A
6001112 Taylor Dec 1999 A
6007530 Dornhofer et al. Dec 1999 A
6010449 Selmon et al. Jan 2000 A
6013072 Winston et al. Jan 2000 A
6017359 Gershony et al. Jan 2000 A
6027514 Stine et al. Feb 2000 A
6032673 Savage et al. Mar 2000 A
6048349 Winston et al. Apr 2000 A
6080170 Nash et al. Jun 2000 A
6106515 Winston et al. Aug 2000 A
6110164 Vidlund Aug 2000 A
6120515 Rogers et al. Sep 2000 A
6120516 Selmon et al. Sep 2000 A
6134002 Stimson et al. Oct 2000 A
6134003 Tearney et al. Oct 2000 A
6152938 Curry Nov 2000 A
6152951 Hashimoto et al. Nov 2000 A
6160826 Swanson et al. Dec 2000 A
6175669 Colston et al. Jan 2001 B1
6176871 Pathak et al. Jan 2001 B1
6183432 Milo Feb 2001 B1
6193676 Winston et al. Feb 2001 B1
6206898 Honeycutt et al. Mar 2001 B1
6228076 Winston et al. May 2001 B1
6241744 Imran et al. Jun 2001 B1
6283957 Hashimoto et al. Sep 2001 B1
6285903 Rosenthal et al. Sep 2001 B1
6290668 Gregory et al. Sep 2001 B1
6294775 Seibel et al. Sep 2001 B1
6299622 Snow et al. Oct 2001 B1
6307985 Murakami et al. Oct 2001 B1
6375615 Flaherty et al. Apr 2002 B1
6402719 Ponzi et al. Jun 2002 B1
6416527 Berg et al. Jul 2002 B1
6445939 Swanson et al. Sep 2002 B1
6445944 Ostrovsky Sep 2002 B1
6447525 Follmer et al. Sep 2002 B2
6451036 Heitzmann et al. Sep 2002 B1
6454717 Pantages et al. Sep 2002 B1
6454779 Taylor Sep 2002 B1
6482216 Hiblar et al. Nov 2002 B1
6482217 Pintor et al. Nov 2002 B1
6485413 Boppart et al. Nov 2002 B1
6497649 Parker et al. Dec 2002 B2
6501551 Tearney et al. Dec 2002 B1
6503261 Bruneau et al. Jan 2003 B1
6511458 Milo et al. Jan 2003 B2
6517528 Pantages et al. Feb 2003 B1
6542665 Reed et al. Apr 2003 B2
6544230 Flaherty et al. Apr 2003 B1
6546272 MacKinnon et al. Apr 2003 B1
6551302 Rosinko et al. Apr 2003 B1
6563105 Seibel et al. May 2003 B2
6564087 Pitris et al. May 2003 B1
6565588 Clement et al. May 2003 B1
6572563 Ouchi et al. Jun 2003 B2
6572643 Gharibadeh Jun 2003 B1
6575995 Huter et al. Jun 2003 B1
6579298 Bruneau et al. Jun 2003 B1
6599296 Gillick et al. Jul 2003 B1
6615071 Casscells, III et al. Sep 2003 B1
6629953 Boyd Oct 2003 B1
6638233 Corvi et al. Oct 2003 B2
6645217 MacKinnon et al. Nov 2003 B1
6657727 Izatt et al. Dec 2003 B1
6666874 Heitzmann et al. Dec 2003 B2
6687010 Horii Feb 2004 B1
6728571 Barbato Apr 2004 B1
D489973 Root et al. May 2004 S
6730063 Delaney et al. May 2004 B2
6758854 Butler et al. Jul 2004 B1
6760112 Reed et al. Jul 2004 B2
6800085 Selmon et al. Oct 2004 B2
6818001 Wulfman et al. Nov 2004 B2
6824550 Noriega et al. Nov 2004 B1
6830577 Nash et al. Dec 2004 B2
6845190 Smithwick et al. Jan 2005 B1
6852109 Winston et al. Feb 2005 B2
6853457 Bjarklev et al. Feb 2005 B2
6856712 Fauver et al. Feb 2005 B2
6867753 Chinthammit et al. Mar 2005 B2
6879851 McNamara et al. Apr 2005 B2
6947787 Webler Sep 2005 B2
6961123 Wang et al. Nov 2005 B1
6970732 Winston et al. Nov 2005 B2
6975898 Seibel Dec 2005 B2
7068878 Crossman-Bosworth et al. Jun 2006 B2
7074231 Jang Jul 2006 B2
7126693 Everett et al. Oct 2006 B2
7172610 Heitzmann et al. Feb 2007 B2
7242480 Alphonse Jul 2007 B2
7261687 Yang Aug 2007 B2
7288087 Winston et al. Oct 2007 B2
7291146 Steinke et al. Nov 2007 B2
7297131 Nita Nov 2007 B2
7311723 Seibel et al. Dec 2007 B2
7344546 Wulfman et al. Mar 2008 B2
7366376 Shishkov et al. Apr 2008 B2
7382949 Bouma et al. Jun 2008 B2
7426036 Feldchtein et al. Sep 2008 B2
7428001 Schowengerdt et al. Sep 2008 B2
7428053 Feldchtein et al. Sep 2008 B2
7455649 Root et al. Nov 2008 B2
7474407 Gutin Jan 2009 B2
7485127 Nistal Feb 2009 B2
7488340 Kauphusman et al. Feb 2009 B2
7530948 Seibel et al. May 2009 B2
7530976 MacMahon et al. May 2009 B2
7538859 Tearney et al. May 2009 B2
7538886 Feldchtein May 2009 B2
7539362 Teramura May 2009 B2
7542145 Toida et al. Jun 2009 B2
7544162 Ohkubo Jun 2009 B2
7545504 Buckland et al. Jun 2009 B2
7555333 Wang et al. Jun 2009 B2
7577471 Camus et al. Aug 2009 B2
7583872 Seibel et al. Sep 2009 B2
7616986 Seibel et al. Nov 2009 B2
7637885 Maschke Dec 2009 B2
7674253 Fisher et al. Mar 2010 B2
7682319 Martin et al. Mar 2010 B2
7706863 Imanishi et al. Apr 2010 B2
7728985 Feldchtein et al. Jun 2010 B2
7729745 Maschke Jun 2010 B2
7734332 Sher Jun 2010 B2
7738945 Fauver et al. Jun 2010 B2
7753852 Maschke Jul 2010 B2
7771425 Dycus et al. Aug 2010 B2
7785286 Magnin et al. Aug 2010 B2
7813609 Petersen et al. Oct 2010 B2
7821643 Amazeen et al. Oct 2010 B2
7824089 Charles Nov 2010 B2
7840283 Bush et al. Nov 2010 B1
7944568 Teramura et al. May 2011 B2
7952718 Li et al. May 2011 B2
7972299 Carter et al. Jul 2011 B2
8059274 Splinter Nov 2011 B2
8062316 Patel et al. Nov 2011 B2
8068921 Prakash et al. Nov 2011 B2
8313493 Fisher Nov 2012 B2
8361097 Patel et al. Jan 2013 B2
8548571 He et al. Oct 2013 B2
8548603 Swoyer et al. Oct 2013 B2
8632557 Thatcher et al. Jan 2014 B2
8644913 Simpson et al. Feb 2014 B2
8647335 Markus Feb 2014 B2
8696695 Patel et al. Apr 2014 B2
8911459 Simpson et al. Dec 2014 B2
9119662 Moberg Sep 2015 B2
9125562 Spencer et al. Sep 2015 B2
9333007 Escudero et al. May 2016 B2
9345398 Tachibana et al. May 2016 B2
9345406 Spencer et al. May 2016 B2
9345510 Patel et al. May 2016 B2
9345511 Smith et al. May 2016 B2
9351757 Kusleika May 2016 B2
9498247 Patel et al. Nov 2016 B2
9498600 Rosenthal et al. Nov 2016 B2
9557156 Kankaria Jan 2017 B2
9572492 Simpson et al. Feb 2017 B2
9592075 Simpson et al. Mar 2017 B2
9642646 Patel et al. May 2017 B2
9788790 Black et al. Oct 2017 B2
9854979 Smith et al. Jan 2018 B2
9918734 Patel et al. Mar 2018 B2
9949754 Newhauser et al. Apr 2018 B2
10052125 Rosenthal et al. Aug 2018 B2
10130386 Simpson et al. Nov 2018 B2
10244934 Tachibana et al. Apr 2019 B2
10335173 Carver et al. Jul 2019 B2
10342491 Black et al. Jul 2019 B2
10349974 Patel et al. Jul 2019 B2
10357277 Patel et al. Jul 2019 B2
10363062 Spencer et al. Jul 2019 B2
20010005788 McGuckin, Jr. Jun 2001 A1
20010020126 Swanson et al. Sep 2001 A1
20020019644 Hastings et al. Feb 2002 A1
20020072706 Hiblar et al. Jun 2002 A1
20020082585 Carrot et al. Jun 2002 A1
20020082626 Donohoe et al. Jun 2002 A1
20020111548 Swanson et al. Aug 2002 A1
20020115931 Strauss et al. Aug 2002 A1
20020147459 Bashiri et al. Oct 2002 A1
20020158547 Wood Oct 2002 A1
20030002038 Mawatari Jan 2003 A1
20030028100 Tearney et al. Feb 2003 A1
20030032880 Moore Feb 2003 A1
20030045835 Anderson et al. Mar 2003 A1
20030095248 Frot May 2003 A1
20030097044 Rovegno May 2003 A1
20030120150 Govari Jun 2003 A1
20030120295 Simpson et al. Jun 2003 A1
20030125756 Shturman et al. Jul 2003 A1
20030125757 Patel et al. Jul 2003 A1
20030125758 Simpson et al. Jul 2003 A1
20030139751 Evans et al. Jul 2003 A1
20030181855 Simpson et al. Sep 2003 A1
20040002650 Mandrusov et al. Jan 2004 A1
20040039371 Tockman et al. Feb 2004 A1
20040057667 Yamada et al. Mar 2004 A1
20040059257 Gaber Mar 2004 A1
20040082850 Bonner et al. Apr 2004 A1
20040092915 Levatter May 2004 A1
20040093001 Hamada May 2004 A1
20040147934 Kiester Jul 2004 A1
20040167553 Simpson et al. Aug 2004 A1
20040167554 Simpson et al. Aug 2004 A1
20040181249 Torrance et al. Sep 2004 A1
20040186368 Ramzipoor et al. Sep 2004 A1
20040193140 Griffin et al. Sep 2004 A1
20040202418 Ghiron et al. Oct 2004 A1
20040220519 Wulfman et al. Nov 2004 A1
20040230212 Wulfman Nov 2004 A1
20040230213 Wulfman et al. Nov 2004 A1
20040236312 Nistal et al. Nov 2004 A1
20040243162 Wulfman et al. Dec 2004 A1
20040254599 Lipoma et al. Dec 2004 A1
20040260236 Manning et al. Dec 2004 A1
20050020925 Kleen et al. Jan 2005 A1
20050043614 Huizenga et al. Feb 2005 A1
20050054947 Goldenberg Mar 2005 A1
20050075660 Chu et al. Apr 2005 A1
20050085708 Fauver et al. Apr 2005 A1
20050085721 Fauver et al. Apr 2005 A1
20050105097 Fang-Yen et al. May 2005 A1
20050141843 Warden et al. Jun 2005 A1
20050154407 Simpson Jul 2005 A1
20050159712 Andersen Jul 2005 A1
20050159731 Lee Jul 2005 A1
20050171478 Selmon et al. Aug 2005 A1
20050177068 Simpson Aug 2005 A1
20050182295 Soper et al. Aug 2005 A1
20050187571 Maschke Aug 2005 A1
20050192496 Maschke Sep 2005 A1
20050197623 Leeflang et al. Sep 2005 A1
20050201662 Petersen et al. Sep 2005 A1
20050203553 Maschke Sep 2005 A1
20050222519 Simpson Oct 2005 A1
20050222663 Simpson et al. Oct 2005 A1
20050251116 Steinke et al. Nov 2005 A1
20060011820 Chow-Shing et al. Jan 2006 A1
20060032508 Simpson Feb 2006 A1
20060046235 Alexander Mar 2006 A1
20060049587 Cornwell Mar 2006 A1
20060064009 Webler et al. Mar 2006 A1
20060084911 Belef et al. Apr 2006 A1
20060109478 Tearney et al. May 2006 A1
20060135870 Webler Jun 2006 A1
20060173475 Lafontaine et al. Aug 2006 A1
20060229646 Sparks Oct 2006 A1
20060229659 Gifford et al. Oct 2006 A1
20060235262 Arnal et al. Oct 2006 A1
20060235366 Simpson Oct 2006 A1
20060236019 Soito et al. Oct 2006 A1
20060239982 Simpson Oct 2006 A1
20060241503 Schmitt et al. Oct 2006 A1
20060244973 Yun et al. Nov 2006 A1
20060252993 Freed et al. Nov 2006 A1
20060264741 Prince Nov 2006 A1
20060264743 Kleen et al. Nov 2006 A1
20060264907 Eskridge et al. Nov 2006 A1
20070010840 Rosenthal et al. Jan 2007 A1
20070015969 Feldman et al. Jan 2007 A1
20070015979 Redel Jan 2007 A1
20070035855 Dickensheets Feb 2007 A1
20070038061 Huennekens et al. Feb 2007 A1
20070038125 Kleen et al. Feb 2007 A1
20070038173 Simpson Feb 2007 A1
20070078469 Soito et al. Apr 2007 A1
20070078500 Ryan et al. Apr 2007 A1
20070081166 Brown et al. Apr 2007 A1
20070088230 Terashi et al. Apr 2007 A1
20070106155 Goodnow et al. May 2007 A1
20070135712 Maschke Jun 2007 A1
20070167710 Unal et al. Jul 2007 A1
20070196926 Soito et al. Aug 2007 A1
20070219484 Straub Sep 2007 A1
20070250080 Jones et al. Oct 2007 A1
20070255252 Mehta Nov 2007 A1
20070270647 Nahen et al. Nov 2007 A1
20070276419 Rosenthal Nov 2007 A1
20070288036 Seshadri Dec 2007 A1
20070299309 Seibel et al. Dec 2007 A1
20080004643 To et al. Jan 2008 A1
20080004644 To et al. Jan 2008 A1
20080004645 To et al. Jan 2008 A1
20080004646 To et al. Jan 2008 A1
20080015491 Bei et al. Jan 2008 A1
20080027334 Langston Jan 2008 A1
20080033396 Danek et al. Feb 2008 A1
20080045986 To et al. Feb 2008 A1
20080049234 Seitz Feb 2008 A1
20080058629 Seibel et al. Mar 2008 A1
20080065124 Olson Mar 2008 A1
20080065125 Olson Mar 2008 A1
20080065205 Nguyen et al. Mar 2008 A1
20080095421 Sun et al. Apr 2008 A1
20080103439 Torrance et al. May 2008 A1
20080103446 Torrance et al. May 2008 A1
20080103516 Wulfman et al. May 2008 A1
20080132929 O'Sullivan et al. Jun 2008 A1
20080139897 Ainsworth et al. Jun 2008 A1
20080146942 Dala-Krishna Jun 2008 A1
20080147000 Seibel et al. Jun 2008 A1
20080154293 Taylor et al. Jun 2008 A1
20080154296 Taylor et al. Jun 2008 A1
20080177138 Courtney et al. Jul 2008 A1
20080186501 Xie Aug 2008 A1
20080207996 Tsai Aug 2008 A1
20080221388 Seibel et al. Sep 2008 A1
20080228033 Tumlinson et al. Sep 2008 A1
20080243030 Seibel et al. Oct 2008 A1
20080243031 Seibel et al. Oct 2008 A1
20080262312 Carroll et al. Oct 2008 A1
20080275485 Bonnette et al. Nov 2008 A1
20090018565 To et al. Jan 2009 A1
20090018566 Escudero et al. Jan 2009 A1
20090018567 Escudero et al. Jan 2009 A1
20090024084 Khosla et al. Jan 2009 A1
20090024085 To et al. Jan 2009 A1
20090024191 Seibel et al. Jan 2009 A1
20090028407 Seibel et al. Jan 2009 A1
20090028507 Jones et al. Jan 2009 A1
20090043191 Castella et al. Feb 2009 A1
20090073444 Wang Mar 2009 A1
20090076447 Casas et al. Mar 2009 A1
20090093764 Pfeffer et al. Apr 2009 A1
20090099641 Wu et al. Apr 2009 A1
20090125019 Douglass et al. May 2009 A1
20090135280 Johnston et al. May 2009 A1
20090137893 Seibel et al. May 2009 A1
20090152664 Tian et al. Jun 2009 A1
20090185135 Volk Jul 2009 A1
20090196554 Irisawa Aug 2009 A1
20090198125 Nakabayashi et al. Aug 2009 A1
20090208143 Yoon et al. Aug 2009 A1
20090216180 Lee et al. Aug 2009 A1
20090221904 Shealy et al. Sep 2009 A1
20090221920 Boppart et al. Sep 2009 A1
20090235396 Wang et al. Sep 2009 A1
20090244485 Walsh et al. Oct 2009 A1
20090244547 Ozawa Oct 2009 A1
20090264826 Thompson Oct 2009 A1
20090284749 Johnson et al. Nov 2009 A1
20090292199 Bielewicz et al. Nov 2009 A1
20090306520 Schmitt et al. Dec 2009 A1
20090316116 Melville et al. Dec 2009 A1
20090318862 Ali et al. Dec 2009 A1
20100004544 Toida Jan 2010 A1
20100021926 Noordin Jan 2010 A1
20100049225 To et al. Feb 2010 A1
20100080016 Fukui et al. Apr 2010 A1
20100082000 Honeck et al. Apr 2010 A1
20100125253 Olson May 2010 A1
20100130996 Doud et al. May 2010 A1
20100217245 Prescott Aug 2010 A1
20100241147 Maschke Sep 2010 A1
20100253949 Adler et al. Oct 2010 A1
20100292539 Lankenau et al. Nov 2010 A1
20100292721 Moberg Nov 2010 A1
20100312263 Moberg et al. Dec 2010 A1
20100317973 Nita Dec 2010 A1
20100324472 Wulfman Dec 2010 A1
20110023617 Yu et al. Feb 2011 A1
20110028977 Rauscher et al. Feb 2011 A1
20110040238 Wulfman et al. Feb 2011 A1
20110058250 Liu et al. Mar 2011 A1
20110060186 Tilson et al. Mar 2011 A1
20110071401 Hastings et al. Mar 2011 A1
20110092955 Purdy et al. Apr 2011 A1
20110106004 Eubanks et al. May 2011 A1
20110118660 Torrance et al. May 2011 A1
20110130777 Zhang et al. Jun 2011 A1
20110144673 Zhang et al. Jun 2011 A1
20110201924 Tearney et al. Aug 2011 A1
20110208222 Ljahnicky et al. Aug 2011 A1
20110257478 Kleiner et al. Oct 2011 A1
20110264125 Wilson et al. Oct 2011 A1
20110270187 Nelson Nov 2011 A1
20110295148 Destoumieux et al. Dec 2011 A1
20110301625 Mauch et al. Dec 2011 A1
20110319905 Palme et al. Dec 2011 A1
20120002928 Irisawa Jan 2012 A1
20120004506 Tearney et al. Jan 2012 A1
20120123352 Fruland et al. May 2012 A1
20120238869 Schmitt et al. Sep 2012 A1
20120259337 del Rio et al. Oct 2012 A1
20120277730 Salahieh et al. Nov 2012 A1
20120289971 Segermark et al. Nov 2012 A1
20130035692 Sorensen et al. Feb 2013 A1
20130072787 Wallace et al. Mar 2013 A1
20130211221 Sunnarborg et al. Aug 2013 A1
20130223798 Jenner et al. Aug 2013 A1
20130223801 Bhagavatula et al. Aug 2013 A1
20130255069 Higashi et al. Oct 2013 A1
20130266259 Bhagavatula et al. Oct 2013 A1
20130287282 Yokota et al. Oct 2013 A1
20130296695 Spencer et al. Nov 2013 A1
20130317519 Romo et al. Nov 2013 A1
20130325003 Kapur et al. Dec 2013 A1
20140005534 He et al. Jan 2014 A1
20140046250 Jain et al. Feb 2014 A1
20140128893 Guggenheimer et al. May 2014 A1
20140187949 Zhao et al. Jul 2014 A1
20140222042 Kessler et al. Aug 2014 A1
20140222047 Vreeman Aug 2014 A1
20140275996 Stigall Sep 2014 A1
20140291985 Cabrera et al. Oct 2014 A1
20140343410 Graf et al. Nov 2014 A1
20140371718 Alvarez et al. Dec 2014 A1
20150025310 Everingham et al. Jan 2015 A1
20150036146 Staloff Feb 2015 A1
20150141816 Gupta et al. May 2015 A1
20150146211 Bhagavatula et al. May 2015 A1
20150320975 Simpson et al. Nov 2015 A1
20160008025 Gupta et al. Jan 2016 A1
20160038030 Smith et al. Feb 2016 A1
20160144155 Simpson et al. May 2016 A1
20160262839 Spencer et al. Sep 2016 A1
20160310700 Drake et al. Oct 2016 A1
20160354109 Guggenheimer et al. Dec 2016 A1
20160354110 Guggenheimer et al. Dec 2016 A1
20170065295 Patel et al. Mar 2017 A1
20170238803 Kankaria Aug 2017 A1
20170238808 Simpson et al. Aug 2017 A1
20170273711 Simpson et al. Sep 2017 A1
20180042520 Patel et al. Feb 2018 A1
20180192880 Patel et al. Jul 2018 A1
20180207417 Zung et al. Jul 2018 A1
20180256039 Smith et al. Sep 2018 A1
20180256187 Patel et al. Sep 2018 A1
20180364024 Baca et al. Dec 2018 A1
20180368688 Simpson et al. Dec 2018 A9
20190021679 Christensen Jan 2019 A1
20190021760 Newhauser et al. Jan 2019 A1
20190029714 Patel et al. Jan 2019 A1
20190110809 Rosenthal et al. Apr 2019 A1
20190159796 Simpson et al. May 2019 A1
20190209206 Patel et al. Jul 2019 A1
Foreign Referenced Citations (97)
Number Date Country
1875242 Dec 2006 CN
1947652 Apr 2007 CN
101601581 Dec 2009 CN
103027727 Apr 2013 CN
104968285 Oct 2015 CN
202006018883.5 Feb 2007 DE
0347098 Dec 1989 EP
0808638 Nov 1997 EP
0845692 Nov 2005 EP
1859732 Nov 2007 EP
2090245 Aug 2009 EP
2353526 Sep 2013 EP
2942028 Nov 2015 EP
S62-275425 Nov 1987 JP
03502060 Feb 1990 JP
05103763 Apr 1993 JP
06027343 Feb 1994 JP
H07184888 Jul 1995 JP
07308393 Nov 1995 JP
2002214127 Jul 2002 JP
2004509695 Apr 2004 JP
2004516073 Jun 2004 JP
2005114473 Apr 2005 JP
2005230550 Sep 2005 JP
2005249704 Sep 2005 JP
2005533533 Nov 2005 JP
2008175698 Jul 2006 JP
2006288775 Oct 2006 JP
2006313158 Nov 2006 JP
2006526790 Nov 2006 JP
2006326157 Dec 2006 JP
200783053 Apr 2007 JP
200783057 Apr 2007 JP
2007225349 Sep 2007 JP
2007533361 Nov 2007 JP
2008023627 Feb 2008 JP
2008128708 Jun 2008 JP
2008145376 Jun 2008 JP
2008183208 Aug 2008 JP
2008253492 Oct 2008 JP
200914751 Jan 2009 JP
2009509690 Mar 2009 JP
200978150 Apr 2009 JP
2009066252 Apr 2009 JP
2009201969 Sep 2009 JP
2010042182 Feb 2010 JP
2010518900 Jun 2010 JP
2011521747 Jul 2011 JP
2012143558 Aug 2012 JP
2012229976 Nov 2012 JP
2012533353 Dec 2012 JP
2013512736 Apr 2013 JP
2013524930 Jun 2013 JP
2015533584 Nov 2015 JP
2016508758 Mar 2016 JP
20070047221 May 2007 KR
2185859 Jul 2002 RU
2218191 Dec 2003 RU
WO9117698 Nov 1991 WO
WO9923958 May 1999 WO
WO0054659 Sep 2000 WO
WO0115609 Mar 2001 WO
WO0176680 Oct 2001 WO
WO2006133030 Dec 2006 WO
WO2008005888 Jan 2008 WO
WO2008029506 Mar 2008 WO
WO2008042987 Apr 2008 WO
WO2008051951 May 2008 WO
WO2008065600 Jun 2008 WO
WO2008086613 Jul 2008 WO
WO2008087613 Jul 2008 WO
WO2009005779 Jan 2009 WO
WO2009006335 Jan 2009 WO
WO2009009799 Jan 2009 WO
WO2009009802 Jan 2009 WO
WO2009023635 Feb 2009 WO
WO2009024344 Feb 2009 WO
WO2009094341 Jul 2009 WO
WO2009140617 Nov 2009 WO
WO2009148317 Dec 2009 WO
WO2010039464 Apr 2010 WO
WO2010056771 May 2010 WO
WO2011044387 Apr 2011 WO
WO2011062087 May 2011 WO
WO2012057940 May 2012 WO
WO2012061935 May 2012 WO
WO2012123737 Sep 2012 WO
WO2012166332 Dec 2012 WO
WO2013033490 Mar 2013 WO
WO2013056262 Apr 2013 WO
WO2014077870 May 2014 WO
WO2014093148 Jun 2014 WO
WO2015074018 May 2015 WO
WO2015101747 Jul 2015 WO
WO2015120146 Aug 2015 WO
WO2015165736 Nov 2015 WO
WO2017007853 Jan 2017 WO
Non-Patent Literature Citations (30)
Entry
Smith et al.: U.S. Appl. No. 16/941,310 entitled “Chronic total occlusion crossing devices with imaging,” filed Jul. 28, 2020.
Spencer et al.; U.S. Appl. No. 16/943,446 entitled “Catheter-based off-axis optical coherence tomography imaging system,” filed Jul. 30, 2020.
Aziz et al.; Chronic total occlusions—a stiff challege requiring a major breakthrough: is there light at the end of the tunnel?; Heart; vol. 91; suppl. III; pp. 42-48; Jun. 2005.
Choma et al.; Sensitivity advantage of swept source and fourier domain optical coherence tomography; Optics Express; 11(18); pp. 2183-2189; Sep. 8, 2003.
De Boer et al.; Improved signal-to-noise ratio in spectral-domain compared with time-domain optical coherence tomography; Optics Letters; 28(21); pp. 2067-2069; Nov. 2003.
Emkey et al.; Analysis and evaluation of graded-index fiber-lenses; Journal of Lightwave Technology; vol. LT-5; No. 9; pp. 1156-1164; Sep. 1987.
Gonzalo et al.; Optical coherence tomography patterns of stent restenosis; Am. Heart J.; 158(2); pp. 284-293; Aug. 2009.
Han et al.; In situ Frog Retina Imaging Using Common-Path OCT with a Gold-Coated Bare Fiber Probe; CFM6; San Jose, California; CLEO, May 4, 2008; 2 pages.
Leitgeb et al.; Performance of fourier domain vs time domain optical coherence tomography; Optics Express; 11(8); pp. 889-894; Apr. 21, 2003.
Linares et al.; Arbitrary single-mode coupling by tapered and nontapered grin fiber lenses; Applied Optics; vol. 29; No. 28; pp. 4003-4007; Oct. 1, 1990.
Muller et al.; Time-gated infrared fourier-domain optical coherence tomography; CFM5; San Jose, California; CLEO May 4, 2008; 2 pages.
Rollins et al.; Optimal interferometer designs for optical coherence tomography; Optics Letters; 24(21); pp. 1484-1486; Nov. 1999.
Sharma et al.; Optical coherence tomography based on an all-fiber autocorrelator using probe-end reflection as reference; CWJ13; San Francisco, California; CLEO May 16, 2004; 4 pages.
Shinkle et al.; Evaluation of stent placement and outcomes with optical coherence tomography; Interv. Cardiol.; 2(4); pp. 535-543; (manuscript version, 12 pages); Aug. 2010.
Suparno et al.; Light scattering with single-mode fiber collimators; Applied Optics; vol. 33; No. 30; pp. 7200-7205; Oct. 20, 1994.
Tanaka et al.; Challenges on the frontier of intracoronary imaging: atherosclerotic plaque macrophage measurement by optical coherence tomography; Journal of Biomedical Optics; 15(1); pp.(011104-1)-(011104-8); Jan.-Feb. 2010.
Wang et al.; Common-path endoscopic Fourier domain OCT with a reference Michelson interferometer; Proceedings of the SPIE; vol. 7566; pp. 75660L-75660L-7; Jan. 2010.
Fernandez et al., U.S. Appl. No. 16/305,136 entitled “Catheter device with detachable distal end,” filed Nov. 28, 2018.
Tachibana et al.; U.S. Appl. No. 16/372,112 entitled “Atherectomy catheter drive assemblies,” filed Apr. 1, 2019.
Radjabi et al.; U.S. Appl. No. 16/347,840 entitled “Methods, systems and apparatuses for displaying real-time catheter position,” filed May 7, 2019.
Patel et al.; U.S. Appl. No. 16/490,903 entitled “Atherctomy catheter,” filed Jul. 2, 2019.
Black et al; U.S. Appl. No. 16/506,851 entitled “Optical coherence tomography for biological imaging,” filed Jul. 9, 2019.
Patel et al.; U.S. Appl. No. 17/046,066 entitled “Occlusion-crossing devices,” filed Oct. 8, 2020.
Simpson et al.; U.S. Appl. No. 17/075,548 entitled “Identification of elastic lamina to guide interventional therapy,” filed Oct. 20, 2020.
Schmitt et al.; A new rotational thrombectomy catheter: System design and first clinical esperiences; Cardiovascular and Interventional Radiology; Sprinver-Verlag; 22(6); pp. 504-509; Nov. 1, 1999.
Patel et al.; U.S. Appl. No. 16/801,047 entitled “Micro-molded anamorphic reflector lens for image guided therapeutic/diagnostic catheters,” filed Feb. 25, 2020.
Stamper et al.; Plaque characterization with optical coherence tomography. Journal of the American College of Cardiology. 47(8); pp. 69-79; Apr. 18, 2006.
Patel et al.; U.S. Appl. No. 16/681,807 entitled “Atherectorny catheters and occlusion crossing devices,” filed Nov. 12, 2019.
Bayer Material Science: ; Snap-Fit Joints to Plastics; 26 pages; retrievers from the Internet: ( https://web.archive.org/web/20121119232733if_/http://fab.cba.mit.edu:80/classes/S62.12/people/vemelle.novel/Plastic_Snap_fit_design.pdf) on Sep. 26, 2016.
Sharma et al.; Common-path optical coherence tomography with side-viewing bare fiber probe for endoscopic optical coherence tomography; vol. 78; 113102; 5 pages; Nov. 6, 2007.
Related Publications (1)
Number Date Country
20200069327 A1 Mar 2020 US
Provisional Applications (2)
Number Date Country
62073850 Oct 2014 US
62022101 Jul 2014 US
Continuations (1)
Number Date Country
Parent 15324325 US
Child 16516093 US